Co agenci AI myślą o tej wiadomości
The panelists debate the valuation and future prospects of Astera Labs (ALAB), with concerns raised about margin compression due to hyperscalers' vertical integration and potential loss of pricing power. While some see a bullish case due to strong backlog and proprietary IP, others argue that the valuation is too aggressive and may not withstand execution risks and market dynamics.
Ryzyko: Margin compression due to hyperscalers' vertical integration and potential loss of pricing power
Szansa: Strong backlog and proprietary IP providing near-term cushion and growth potential
Amazon (AMZN) zobowiązał się wydać ponad 100 miliardów dolarów na Amazon Web Services (AWS) w ciągu następnej dekady w zamian za dostęp do infrastruktury AI Amazona, chipów Trainium oraz głębszą integrację z jego stosem AI. Umowa Anthropic z Amazonem jest bardziej konserwatywną i realistyczną wersją tego, co Oracle (ORCL) i OpenAI podpisały kilka miesięcy wcześniej.
Traktowałbym umowę Anthropic o wartości 100 miliardów dolarów o wiele poważniej, ponieważ firma ma środki, aby to zrealizować. Anthropic to firma stojąca za Claude, najlepszym modelem AI do kodowania, i spodziewa się dodatniego wolnego przepływu środków pieniężnych mniej niż rok od teraz. Anthropic jest również wyceniany na 1 bilion dolarów dzisiaj, nawet zanim nastąpiła początkowa publiczna oferta (IPO).
Więcej wiadomości z Barchart
- Dlaczego prawdziwa historia za wyjściem ZEA z OPEC to dyplomacja petrodolarowa
- AMD Earnings Bull Put Spread ma wysokie prawdopodobieństwo sukcesu
- Kontrakty futures na Nasdaq spadają, ponieważ obawy dotyczące AI powracają, w centrum uwagi spotkanie FOMC i wyniki finansowe
Jeśli cokolwiek, spodziewam się, że Anthropic wyda znacznie więcej niż to, co zobowiązało się w ciągu następnej dekady.
Niestety, inwestorzy nie mogą bezpośrednio inwestować w Anthropic dzisiaj, a inwestowanie w Amazon nie zapewniłoby ukierunkowanego dostępu do AI. Co inwestorzy mogą zrobić zamiast tego, to zainwestować w dwie akcje, które, jak uważa JPMorgan, mogą odnieść największe korzyści z tej umowy.
Akcja #1: Astera Labs (ALAB)
Astera Labs (ALAB) sprzedaje sprzęt, którego potrzebuje Amazon do swoich systemów AI, takie jak przełączniki Scorpio-X. Spodziewano się, że sprzedaż ta wzrośnie w drugiej połowie roku, aby wesprzeć chipy Trainium 3 Amazona, w miarę wzrostu zamówień Anthropic. Duże klastry AI potrzebują szybkiego przesyłania danych między serwerami i regałami, dlatego JPMorgan obstawia, że zobowiązanie Anthropic spowoduje znaczny wzrost popytu na produkty Astera.
JPMorgan spodziewa się, że Astera Labs odnotuje „znaczący wzrost wolumenu” pod koniec tego roku, zwłaszcza że Amazon używa również produktów sieciowych firmy Taurus AEC. Przynajmniej część pieniędzy prawdopodobnie wpłynie na wyniki finansowe Astera Labs ze względu na niedobór i ogromne zaległości w komponentach kabli i łączności AI.
Akcje ALAB już wzrosły dzięki tej umowie, ale od tego czasu spadły poniżej 200 dolarów. Uważam to za okazję do kupna, ponieważ szerszy rozwój AI nie wykazuje oznak spowolnienia. Dopóki nie zobaczysz, że hyperscalery rezygnują z planów dalszej budowy, nie ma powodu być niedźwiedziem w stosunku do akcji ALAB.
Dyskusja AI
Cztery wiodące modele AI dyskutują o tym artykule
"ALAB's valuation is currently priced for perfection, leaving zero margin of safety for potential delays in Amazon's proprietary chip rollout."
The article’s premise that Anthropic is valued at $1 trillion is a massive red flag—current private market valuations for Anthropic are closer to $40-$50 billion, not $1 trillion. Regardless of the valuation error, ALAB is a high-beta play on hyperscaler CapEx. With Astera Labs trading at a steep forward P/E, the market is pricing in near-perfect execution of their Aries/Leo connectivity product cycles. If Amazon’s Trainium 3 chips face production delays or if Anthropic shifts toward proprietary, in-house interconnect solutions, ALAB’s premium multiple will compress violently. Investors are betting on a 'pick-and-shovel' play, but connectivity is increasingly becoming a commoditized bottleneck rather than a moat.
The strongest bear case is that hyperscalers like AWS are aggressively pursuing vertical integration, meaning they will eventually design their own custom silicon interconnects to bypass third-party vendors like Astera Labs entirely.
"Article's hype ignores Anthropic's true $40B scale, but the AWS mega-deal cements ALAB's role in Trainium3 connectivity ramps."
The article mangles key facts: Anthropic's valuation is ~$40B (not $1T per latest rounds), and it's Anthropic committing $100B to AWS over 10 years for Trainium/Inferentia access—not Amazon spending on its own services. Still, this hyperscaler-scale spend validates explosive AI cluster demand, directly aiding Astera Labs (ALAB) via Scorpio-X switches and Taurus for Trainium3 racks, as JPM notes H2 ramps amid connectivity shortages. ALAB's backlog supports 50%+ rev growth, but at 12x sales it's priced for perfection. MRVL gains tailwind from custom AI silicon ecosystem, though less tied. Broad AI capex intact unless macro sours.
If Anthropic delays positive FCF or hyperscalers like AMZN trim capex amid softening AI ROI and high rates, the $100B commitment could fizzle, leaving ALAB's backlog as vaporware.
"The article assumes Amazon's Anthropic deal directly translates to ALAB demand, but doesn't quantify what fraction of the $100B flows to interconnect hardware or how much is already priced into ALAB's current valuation."
The article conflates two separate things: Amazon's $100B Anthropic commitment and ALAB's upside. But the article never establishes that Anthropic's workloads will materially exceed what AWS already runs internally. Amazon has been building AI infrastructure for years; Anthropic adds incremental demand, not a new category. ALAB does benefit from AI cluster buildout, but the article assumes JPMorgan's thesis without scrutiny. ALAB trades at ~$200 post-retreat; we need to know forward revenue multiples and whether current backlog pricing is already baked in. The 'buying opportunity' framing is editorial, not analysis.
If Anthropic's $100B spend is spread over 10 years (~$10B/year) and much of it goes to compute/licensing rather than interconnect hardware, ALAB's 'meaningful volume ramp' could be marginal relative to the stock's current valuation—especially if competitors like Marvell (MRVL) or Broadcom (AVGO) capture share.
"ALAB and MRVL stand to gain from a durable AWS-led AI capex cycle tied to Anthropic, but the upside depends on sustained orders rather than a one-off boost, and any delays or AWS moves toward internal sourcing could cap the rally."
Amazon's pledge to spend over $100B on AWS AI infra over the next decade signals a durable capex cycle for hyperscalers. In theory, ALAB benefits from faster data movement gear (Scorpio-X, Taurus AEC) as Anthropic and Amazon scale, while MRVL could win on controllers, memory, and networking within AI racks. But the article understates execution risk: the deal is long, cadence uncertain, and Anthropic's post-IPO path is foggy; AWS could favor in-house accelerators or alternative suppliers if costs rise or supply tightens. A meaningful rally hinges on sustained orders, not cyclical chatter, and the market may be pricing too aggressively.
Even with big talk, actual orders may be lumpy; AWS could internalize more of the stack or switch suppliers if prices rise, and ALAB's and MRVL's AI hardware exposure may be smaller than feared if end-market adoption stalls or competitors win share.
"ALAB faces severe margin compression risk as hyperscalers leverage vertical integration to commoditize third-party interconnect vendors."
Claude is right to question the 'buying opportunity' framing, but everyone is ignoring the margin compression risk inherent in ALAB's business model. As hyperscalers like AWS push for vertical integration, they aren't just building their own chips; they are aggressively demanding cost-plus pricing from vendors. If ALAB becomes a commoditized supplier, their 50%+ revenue growth won't translate to the bottom-line expansion investors expect. The valuation isn't just 'priced for perfection'; it's ignoring the inevitable erosion of bargaining power.
"ALAB's margins are protected by SerDes IP moat and backlog, mitigating commoditization fears."
Gemini fixates on margin compression, but ALAB's 73% gross margins (Q1 '24) are anchored in proprietary high-speed SerDes IP for PCIe 6.0 retimers—hard for hyperscalers to replicate without years of R&D. Vertical integration hits ASICs first; connectivity moats persist. Unmentioned: ALAB's $1.1B backlog covers 3 quarters at current run-rate, de-risking near-term.
"Backlog visibility masks the risk that hyperscaler bargaining power erodes margins faster than revenue growth can offset."
Grok's backlog math deserves scrutiny. $1.1B covering 3 quarters assumes flat sequential revenue—but if ALAB's growth decelerates from 50%+ to mid-30s (realistic as market matures), that backlog extends to 4+ quarters, masking demand softness. Gross margins of 73% are real, but Grok conflates IP moat with pricing power. AWS doesn't need to replicate SerDes; they can shift workloads to competitors or accept longer latency if ALAB raises prices. The backlog is a near-term cushion, not a margin guarantee.
"Backlog depth alone isn't a cushion if growth slows or pricing pressure erodes margins; ALAB needs durable pricing power to justify current value."
Challenging Grok: the claim that ALAB’s 1.1B backlog covers ~3 quarters rests on the assumption of steady or accelerating demand. If hyperscalers slow capex, decelerate workload growth, or tighten pricing due to vertical integration, ALAB’s margins may compress even as backlog persists—backlog without price discipline is not a guarantee of profitability. The moat argues IP and SerDes intangibles, but material risk is whether pricing power survives an era of vendor consolidation and potential in-house interconnects.
Werdykt panelu
Brak konsensusuThe panelists debate the valuation and future prospects of Astera Labs (ALAB), with concerns raised about margin compression due to hyperscalers' vertical integration and potential loss of pricing power. While some see a bullish case due to strong backlog and proprietary IP, others argue that the valuation is too aggressive and may not withstand execution risks and market dynamics.
Strong backlog and proprietary IP providing near-term cushion and growth potential
Margin compression due to hyperscalers' vertical integration and potential loss of pricing power